Sort   by:  
 Page size 
UnknownQuality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
Not available
S-EPMC6804841 | biostudies-literature
UnknownCan immune biomarkers predict benefit from targeted agents in metastatic renal cell carcinoma?
Not available
S-EPMC6976423 | biostudies-literature
UnknownExperience with sunitinib in the treatment of metastatic renal cell carcinoma.
Not available
S-EPMC3441135 | biostudies-literature
UnknownPsychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review.
Not available
S-EPMC9657659 | biostudies-literature
UnknownOutcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines.
Not available
S-EPMC8261552 | biostudies-literature
UnknownPhysical Activity and Body Composition Are Associated With Severity and Risk of Depression, and Serum Lipids.
Not available
S-EPMC7292005 | biostudies-literature
UnknownCharacterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance.
Not available
S-EPMC4987997 | biostudies-literature
UnknownAdipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues.
Not available
S-EPMC3518122 | biostudies-literature
UnknownFrequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
Not available
S-EPMC6119137 | biostudies-literature
UnknownRenal cell carcinoma.
Not available
S-EPMC5936048 | biostudies-literature
Sort   by:  
 Page size